This inventor holds 3 USPTO granted patents. Top assignee: Nippon Oil Fats Co., Ltd.. Active years: 1981-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1984
Title: Shinichi Akimoto: Innovator in Suppository Base Composition
Introduction
Shinichi Akimoto is a notable inventor based in Machida, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of suppository base compositions. With a total of 3 patents to his name, Akimoto's work has garnered attention for its innovative approaches to drug delivery systems.
Latest Patents
Akimoto's latest patents include a unique suppository base composition that comprises 5-80% by weight of polyethylene glycol, 5-80% by weight of triglyceride of fatty acid having 6-22 carbon atoms, and 5-80% by weight of a specifically limited alkylene oxide derivative. This composition has a melting point of 30°C-60°C, demonstrating compatibility with both polar and non-polar drug components. It provides suppositories that exhibit excellent moldability and storage stability. Another patent focuses on a molded, storage-stable suppository base composition with similar components and benefits, further emphasizing his expertise in this area.
Career Highlights
Shinichi Akimoto is currently associated with Nippon Oil Fats Co., Ltd., where he continues to innovate in the field of pharmaceutical formulations. His work has not only advanced the technology behind suppository bases but has also contributed to the overall improvement of drug delivery methods.
Collaborations
Akimoto has collaborated with notable colleagues such as Mitsuo Mizuno and Akinori Suginaka, enhancing the research and development efforts within his field.
Conclusion
Shinichi Akimoto's contributions to the development of suppository base compositions highlight his role as a key innovator in pharmaceutical technology. His patents reflect a commitment to improving drug delivery systems, making a significant impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile